Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.


CSE:BIOV - Post by User

Post by frankmanon Dec 05, 2024 10:19am
59 Views
Post# 36347066

I see my .06 bid on the order depth chart moving up/ L2 ord

I see my .06 bid on the order depth chart moving up/ L2 ord I am going to enter a second bid for my trading shares (not many maybe 40k shares alltogether) closer to months end as tax loss season comes to an end. There should be a couple more news updates by year end (maybe also the bulk sample re acquisition). There will be continuous news developments in 2025.

Bid   Ask
Broker Size Price   Price Size Broker
79 CIBC 70,000 0.06   0.07 38,000 1 Anonymous
19 Desjardins 2,000 0.06   0.07 50,000 124 Questrade
7 TD Sec 1,000 0.06   0.07 30,000 79 CIBC
79 CIBC 30,000 0.06   0.07 10,000 1 Anonymous
7 TD Sec 13,500 0.06   0.07 18,000 79 CIBC
36 Latimer 15,000 0.06   0.075 30,000 79 CIBC
79 CIBC 15,000 0.06   0.075 5,000 7 TD Sec
7 TD Sec 16,000 0.06   0.075 2,000 19 Desjardins
7 TD Sec 10,000 0.06   0.075 10,000 80 National Bank
79 CIBC 3,000 0.06   0.075 1,000 80 National Bank


<< Previous
Bullboard Posts
Next >>